Daniel Hartman (2019)

Daniel HartmanDaniel L. Hartman, M.D., joined the Bill & Melinda Gates Foundation in 2012 as the director of Integrated Development and leads a team that provides technical expertise in drug and diagnostic development. Under his leadership, Integrated Development works closely with the Foundation’s strategy teams to manage product pipelines through clinical trials and to provide help with manufacturing, compliance and regulatory strategy/intelligence. Hartman joined the Foundation after four years as president and chief executive officer of Great Lakes Development, Inc., a consulting company that provides strategic and operational support for early drug development projects. Previously, Hartman served as senior vice president of product development at deCODE genetics, executive director of Pfizer Global Research and Development and vice president of Global Clinical Development at Esperion Therapeutics. He also has held senior clinical research positions at Eli Lilly & Company and is a member of the Scientific Medical Advisory Board at Hopen Life Science Ventures. Hartman received his bachelor’s degree from Calvin College and his medical degree from Wayne State University. He trained in internal medicine and completed a fellowship in pulmonary medicine at Indiana University, where he was chief medical resident.